Related Experiment Video

Updated: Jun 16, 2026

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

Exploiting cellular senescence to treat cancer and circumvent drug resistance

Qin Yan1, Narendra Wajapeyee

  • 1Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. qin.yan@yale.edu

Cancer Biology & Therapy
|February 2, 2010
PubMed

Insights

Cellular senescence, a key regulator of tumor suppression, plays a vital role in cancer initiation and progression. Understanding its mechanisms offers new therapeutic targets for cancer treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Genetics

Background:

  • Human cancers develop from genetic and epigenetic alterations that disrupt tumor suppressor and oncogene functions.
  • Cellular senescence is a critical mechanism preventing neoplastic transformation, impacting cancer initiation, progression, and maintenance.
  • Senescence is induced by chemotherapy and linked to cancer recurrence and drug resistance.

Purpose of the Study:

  • To review the mechanisms and regulation of three major forms of cellular senescence: replicative senescence (RS), oncogene-induced senescence (OIS), and accelerated cellular senescence (ACS).
  • To discuss the role of cellular senescence in human cancer.
  • To explore high-throughput genomics methods for identifying senescence regulators and potential therapeutic targets.

Main Methods:

  • Literature review focusing on cellular senescence mechanisms.
  • Analysis of the role of senescence in cancer development and progression.
  • Discussion of genomics-based approaches for identifying senescence regulators.

Main Results:

  • Cellular senescence is a multifaceted process influencing multiple stages of cancer.
  • Senescence is implicated in both tumor suppression and, in some contexts, cancer recurrence and drug resistance.
  • Genomics approaches are crucial for uncovering senescence regulators.

Conclusions:

  • Understanding the regulation of chemotherapy-induced cellular senescence is key to developing targeted cancer therapies.
  • Cellular senescence presents promising targets for novel anti-cancer strategies.
  • Targeting cellular senescence could lead to alternative and effective cancer treatments.

More Related Videos

Techniques to Induce and Quantify Cellular Senescence06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...